Option Care Health Q4 2023 Earnings Report
Key Takeaways
Option Care Health reported Q4 2023 financial results, with a revenue of $1,124.4 million, a 9.5% increase compared to Q4 2022. Net income was $57.2 million, or $0.32 earnings per share. Adjusted EBITDA reached $111.6 million, an 18.4% increase compared to the prior year. The company also fulfilled $250 million in share repurchases and authorized an additional $250 million.
Net revenue increased by 9.5% to $1,124.4 million compared to Q4 2022.
Gross profit increased by 6.9% to $247.1 million, representing 22.0% of revenue.
Net income increased to $57.2 million, or $0.32 earnings per share.
Adjusted EBITDA increased by 18.4% to $111.6 million.
Option Care Health
Option Care Health
Forward Guidance
For the full year 2024, Option Care Health expects to deliver net revenue of $4.6 billion to $4.8 billion, adjusted EBITDA of $425 million to $450 million, and cash flow from operations of at least $300 million. The Company anticipates an effective tax rate of 26% - 28% and net interest expense of approximately $55 million to $60 million.
Positive Outlook
- Net revenue of $4.6 billion to $4.8 billion
- Adjusted EBITDA of $425 million to $450 million
- Cash flow from operations of at least $300 million
- Effective tax rate of 26% - 28%
- Net interest expense of approximately $55 million to $60 million